HB 830 Louisiana House · 2024 Regular Session

DRUGS/CONTROLLED: Adds Tianeptine to Schedule I of the Uniform Controlled Dangerous Substance Law

This Louisiana bill adds Tianeptine, a substance increasingly used for its sedative effects, to Schedule I of the state's Uniform Controlled Dangerous Substances Law. By placing it in this category, the legislation classifies Tianeptine as having a high potential for abuse and no currently accepted medical use within the state. The law applies to any material containing Tianeptine, including its salts and isomers, unless it is part of a product approved by the U.S. Food and Drug Administration. Consequently, this change subjects the substance to the strictest level of regulation, making possession, distribution, and use subject to criminal penalties similar to those for other Schedule I drugs.
Bill status signed all 5 stages cleared
Introduction
Apr 2024
Committee Review
May 2024
House Passage
Apr 2024
Senate Passage
May 2024
Signed into Law
Jun 2024
Introduced Apr 2, 2024 Signed Jun 19, 2024
Floor votes · Senate May 28, 2024 · House Apr 16, 2024

How they voted

350
Passed · 2 other
Total votes 37
May 28, 2024
D Democratic12
11 Yea 1
91% Yea
R Republican25
24 Yea 1
96% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
20
Key actions
4
Committee
4
May 28, 2024
Upper · Passed
Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
upper
May 15, 2024
Committee
Read by title and referred to the Legislative Bureau.
upper
May 14, 2024
Upper · Passed
Reported favorably.
upper
Apr 16, 2024
Lower · Passed
Read third time by title, roll called on final passage, yeas 99, nays 0. Finally passed, title adopted, ordered to the Senate.
lower
Apr 9, 2024
Lower · Passed
Reported favorably (11-0).
lower
Apr 3, 2024
Committee
Read by title, under the rules, referred to the Committee on Administration of Criminal Justice.
lower
1 primary · 26 co-sponsors

Sponsors